Yu-Sheng Chao

1.3k total citations
23 papers, 901 citations indexed

About

Yu-Sheng Chao is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yu-Sheng Chao has authored 23 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yu-Sheng Chao's work include Click Chemistry and Applications (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Receptor Mechanisms and Signaling (3 papers). Yu-Sheng Chao is often cited by papers focused on Click Chemistry and Applications (3 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Receptor Mechanisms and Signaling (3 papers). Yu-Sheng Chao collaborates with scholars based in Taiwan, United States and India. Yu-Sheng Chao's co-authors include Hsing‐Pang Hsieh, Mohane Selvaraj Coumar, Hui-Yi Shiao, Jian-Sung Wu, Su‐Chin Chen, Wen‐Hsing Lin, John T.-A. Hsu, Hwan-Wun Liu, Su‐Ying Wu and Chang‐Jer Wu and has published in prestigious journals such as Nucleic Acids Research, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Yu-Sheng Chao

23 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu-Sheng Chao Taiwan 14 340 276 202 125 107 23 901
Susan M. Keenan United States 19 426 1.3× 243 0.9× 144 0.7× 130 1.0× 284 2.7× 36 962
Salvatore Ferla United Kingdom 20 314 0.9× 426 1.5× 183 0.9× 76 0.6× 142 1.3× 60 1.1k
Andrew M. Lynn India 20 386 1.1× 105 0.4× 190 0.9× 108 0.9× 140 1.3× 46 1.0k
Cédric Logé France 20 402 1.2× 557 2.0× 299 1.5× 102 0.8× 42 0.4× 46 1.2k
Prija Ponnan India 15 216 0.6× 272 1.0× 110 0.5× 59 0.5× 83 0.8× 33 558
Richard A. Stanton United States 12 343 1.0× 212 0.8× 105 0.5× 120 1.0× 56 0.5× 27 803
Shafinaz F. Chowdhury Canada 14 465 1.4× 185 0.7× 64 0.3× 104 0.8× 111 1.0× 21 850
Anderson Assunção Andrade Brazil 16 217 0.6× 168 0.6× 131 0.6× 114 0.9× 107 1.0× 30 900
Bryan K. S. Yeung United States 18 332 1.0× 348 1.3× 78 0.4× 111 0.9× 426 4.0× 33 1.0k

Countries citing papers authored by Yu-Sheng Chao

Since Specialization
Citations

This map shows the geographic impact of Yu-Sheng Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Sheng Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Sheng Chao more than expected).

Fields of papers citing papers by Yu-Sheng Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Sheng Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Sheng Chao. The network helps show where Yu-Sheng Chao may publish in the future.

Co-authorship network of co-authors of Yu-Sheng Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Sheng Chao. A scholar is included among the top collaborators of Yu-Sheng Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Sheng Chao. Yu-Sheng Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Shu‐Yu, Yi-Yu Ke, Ping‐Yee Law, et al.. (2019). The in vivo antinociceptive and μ-opioid receptor activating effects of the combination of N-phenyl-2′,4′-dimethyl-4,5′-bi-1,3-thiazol-2-amines and naloxone. European Journal of Medicinal Chemistry. 167. 312–323. 7 indexed citations
2.
Chen, Chiung-Tong, John T.-A. Hsu, Wen‐Hsing Lin, et al.. (2015). Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations. European Journal of Medicinal Chemistry. 100. 151–161. 8 indexed citations
3.
Chou, Yu‐Chi, et al.. (2015). Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells. Molecular and Cellular Biology. 35(14). 2541–2553. 32 indexed citations
4.
Chao, Po-Kuan, Jian‐Ying Chuang, Ping‐Yee Law, et al.. (2014). Morphine drives internal ribosome entry site-mediated hnRNP K translation in neurons through opioid receptor-dependent signaling. Nucleic Acids Research. 42(21). 13012–13025. 16 indexed citations
5.
Law, Ping‐Yee, Horace H. Loh, Yu-Sheng Chao, et al.. (2014). Discovery, structure–activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists. Bioorganic & Medicinal Chemistry. 22(17). 4694–4703. 12 indexed citations
6.
Yeh, Teng-Kuang, Jen-Shin Song, Yung‐Ning Yang, et al.. (2013). BPR0C305, an orally active microtubule-disrupting anticancer agent. Anti-Cancer Drugs. 24(10). 1047–1057. 7 indexed citations
7.
Tsai, Ming‐Han, Szu‐Yuan Pu, Ren‐Huang Wu, et al.. (2013). Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus. Antiviral Research. 98(2). 228–241. 26 indexed citations
8.
Shiao, Hui-Yi, John Hsu, Jian-Sung Wu, et al.. (2013). Protein Kinase Inhibitor Design by Targeting the Asp-Phe-Gly (DFG) Motif: The Role of the DFG Motif in the Design of Epidermal Growth Factor Receptor Inhibitors. Journal of Medicinal Chemistry. 56(10). 3889–3903. 109 indexed citations
9.
Tsou, Hsiao‐Hui, Yiu‐Kay Lai, Wen‐Sen Lee, et al.. (2012). Putative tumor metastasis-associated genes in human gastric cancer. International Journal of Oncology. 41(3). 1068–1084. 1 indexed citations
10.
11.
Pu, Szu‐Yuan, Ren‐Huang Wu, Tzu‐Ming Jao, et al.. (2011). Successful Propagation of Flavivirus Infectious cDNAs by a Novel Method To Reduce the Cryptic Bacterial Promoter Activity of Virus Genomes. Journal of Virology. 85(6). 2927–2941. 88 indexed citations
12.
Ke, Yi-Yu, Hui-Yi Shiao, Hsing‐Pang Hsieh, et al.. (2011). Inhibition of HIV-1 Tat-Mediated Transcription by a Coumarin Derivative, BPRHIV001, through the Akt Pathway. Journal of Virology. 85(17). 9114–9126. 25 indexed citations
13.
Chen, Ching-Ping, Kai‐Chia Yeh, Jen-Shin Song, et al.. (2010). Antiangiogenic activities and cisplatin-combined antitumor activities of BPR0L075.. PubMed. 30(7). 2813–22. 12 indexed citations
14.
Lin, Chia‐Hui, Mohane Selvaraj Coumar, Santhosh Kumar Chittimalla, et al.. (2009). Design and Structural Analysis of Novel Pharmacophores for Potent and Selective Peroxisome Proliferator-activated Receptor γ Agonists. Journal of Medicinal Chemistry. 52(8). 2618–2622. 18 indexed citations
15.
Coumar, Mohane Selvaraj, Jian-Sung Wu, Chung‐Yu Chang, et al.. (2008). Aurora kinase A inhibitors: Identification, SAR exploration and molecular modeling of 6,7-dihydro-4H-pyrazolo-[1,5-a]pyrrolo[3,4-d]pyrimidine-5,8-dione scaffold. Bioorganic & Medicinal Chemistry Letters. 18(5). 1623–1627. 24 indexed citations
16.
Yao, Hsien‐Tsung, Yu-Shan Wu, Yi‐Wei Chang, et al.. (2007). Biotransformation of 6-Methoxy-3-(3′,4′,5′-trimethoxy-benzoyl)-1H-indole (BPR0L075), a Novel Antimicrotubule Agent, by Mouse, Rat, Dog, and Human Liver Microsomes. Drug Metabolism and Disposition. 35(7). 1042–1049. 10 indexed citations
17.
Hung, Ming‐Shiu, Jen-Shin Song, Min‐Tsang Hsieh, et al.. (2007). Design, synthesis, and biological evaluation of novel alkenylthiophenes as potent and selective CB1 cannabinoid receptor antagonists. Organic & Biomolecular Chemistry. 6(3). 447–450. 10 indexed citations
18.
Chang, Yi‐Wei, Wei-Cheng Chen, Ling‐Yin Chang, et al.. (2006). Development and validation of a liquid chromatography–tandem mass spectrometry for the determination of BPR0L075, a novel antimicrotuble agent, in rat plasma: Application to a pharmacokinetic study. Journal of Chromatography B. 846(1-2). 162–168. 7 indexed citations
19.
Coumar, Mohane Selvaraj, Tsu Hsu, Hsing‐Pang Hsieh, et al.. (2006). Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(12). 3268–3272. 16 indexed citations
20.
Wu, Chang‐Jer, Jia-Tsrong Jan, Hsing‐Pang Hsieh, et al.. (2004). Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide. Antimicrobial Agents and Chemotherapy. 48(7). 2693–2696. 189 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan M. Keenan Breakdown of academic impact, for papers by Salvatore Ferla Breakdown of academic impact, for papers by Andrew M. Lynn Breakdown of academic impact, for papers by Cédric Logé Breakdown of academic impact, for papers by Prija Ponnan Breakdown of academic impact, for papers by Richard A. Stanton Breakdown of academic impact, for papers by Shafinaz F. Chowdhury Breakdown of academic impact, for papers by Anderson Assunção Andrade Breakdown of academic impact, for papers by Bryan K. S. Yeung
Rankless by CCL
2026